Functional imaging of subthalamic nucleus deep brain stimulation in Parkinson's disease

Movement Disorders

Volumn 26, Issue 10, 2011, Pages 1835-1843

  Boertien, Tessel ^a,b   Zrinzo, Ludvic ^a,c   Kahan, Joshua ^a   Jahanshahi, Marjan ^a   Hariz, Marwan ^a,c   Mancini, Laura ^a,c,d   Limousin, Patricia ^a   Foltynie, Thomas ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^d UCLH NHS Foundation Trust ^*  (United Kingdom)

Author keywords

Functional imaging; Functional magnetic resonance imaging; deep brain stimulation; subthalamic nucleus; Parkinson's disease

Indexed keywords

FLUORODEOXYGLUCOSE F 18; WATER O 15;

BASAL GANGLION; BOLD SIGNAL; BRAIN BLOOD FLOW; BRAIN DEPTH STIMULATION; CAUDATE NUCLEUS; CEREBELLUM; CORPUS STRIATUM; DEPRESSION; ELECTRODE; ELECTROENCEPHALOGRAPHY; EMOTION; EXECUTIVE FUNCTION; FINGER; FLUENCY DISORDER; FUSIFORM GYRUS; HUMAN; IMPULSIVENESS; INFERIOR FRONTAL GYRUS; INSULA; MANIA; MENTAL PERFORMANCE; MESENCEPHALON; MIDDLE FRONTAL GYRUS; MOOD; MOTOR PERFORMANCE; NERVE CELL EXCITABILITY; NEUROIMAGING; NEUROTRANSMISSION; PARIETAL CORTEX; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRECUNEUS; PREMOTOR CORTEX; PRIMARY MOTOR CORTEX; PRIORITY JOURNAL; PUTAMEN; REST; REVIEW; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION; SYSTEMATIC REVIEW (TOPIC); TASK PERFORMANCE; THALAMUS; ZONA INCERTA;

BRAIN; DEEP BRAIN STIMULATION; HUMANS; NEUROIMAGING; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; REST; SUBTHALAMIC NUCLEUS;

EID: 80052261745     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23788     Document Type: Review

References (89)

1. Limousin P, Pollak P, Benazzouz A, et al. Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 1995; 345: 91-95.
2. Krack P, Batir A, van Blercom N, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003; 349: 1925-1934.
3. Benabid AL, Chabardes S, Mitrofanis J, Pollak P. Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease. Lancet Neurol 2009; 8: 67-81.
4. Foltynie T, Zrinzo L, Martinez-Torres I, et al. MRI-guided STN DBS in Parkinson's disease without microelectrode recording: efficacy and safety. J Neurol Neurosurg Psychiatry 2011; 82: 358-363.
5. Derost PP, Ouchchane L, Morand D, et al. Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population? Neurology 2007; 68: 1345-1355.
6. Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006; 355: 896-908.
7. Lagrange E, Krack P, Moro E, et al. Bilateral subthalamic nucleus stimulation improves health-related quality of life in PD. Neurology 2002; 59: 1976-1978.
8. Parsons TD, Rogers SA, Braaten AJ, Woods SP, Troster AI. Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a meta-analysis. Lancet Neurol 2006; 5: 578-588.
9. Tripoliti E, Zrinzo L, Martinez-Torres I, et al. Effects of contact location and voltage amplitude on speech and movement in bilateral subthalamic nucleus deep brain stimulation. Mov Disord 2008; 23: 2377-2383.
10. Limousin P, Martinez-Torres I. Deep brain stimulation for Parkinson's disease. Neurotherapeutics 2008; 5: 309-319.
11. Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci 1989; 12: 366-375.
12. McIntyre CC, Savasta M, Kerkerian-Le GL, Vitek JL. Uncovering the mechanism(s) of action of deep brain stimulation: activation, inhibition, or both. Clin Neurophysiol 2004; 115: 1239-1248.
13. Johnson MD, Miocinovic S, McIntyre CC, Vitek JL. Mechanisms and targets of deep brain stimulation in movement disorders. Neurotherapeutics 2008; 5: 294-308.
14. Hammond C, Bergman H, Brown P. Pathological synchronization in Parkinson's disease: networks, models and treatments. Trends Neurosci 2007; 30: 357-364.
15. Gatev P, Darbin O, Wichmann T. Oscillations in the basal ganglia under normal conditions and in movement disorders. Mov Disord 2006; 21: 1566-1577.
16. Hammond C, Ammari R, Bioulac B, Garcia L. Latest view on the mechanism of action of deep brain stimulation. Mov Disord 2008; 23: 2111-2121.
17. Cilia R, Marotta G, Landi A, et al. Clinical and cerebral activity changes induced by subthalamic nucleus stimulation in advanced Parkinson's disease: a prospective case-control study. Clin Neurol Neurosurg 2009; 111: 140-146.
18. Pogosyan A, Yoshida F, Chen CC, et al. Parkinsonian impairment correlates with spatially extensive subthalamic oscillatory synchronization. Neuroscience 2010; 171: 245-257.
19. Hirano S, Asanuma K, Ma Y, et al. Dissociation of metabolic and neurovascular responses to levodopa in the treatment of Parkinson's disease. J Neurosci 2008; 28: 4201-4209.
20. Fukuda M, Mentis MJ, Ma Y, et al. Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: a PET study of resting-state glucose metabolism. Brain 2001; 124: 1601-1609.
21. Trost M, Su S, Su P, et al. Network modulation by the subthalamic nucleus in the treatment of Parkinson's disease. Neuroimage 2006; 31: 301-307.
22. Asanuma K, Tang C, Ma Y, et al. Network modulation in the treatment of Parkinson's disease. Brain 2006; 129: 2667-2678.
23. Huang C, Tang C, Feigin A, et al. Changes in network activity with the progression of Parkinson's disease. Brain 2007; 130: 1834-1846.
24. Hirano S, Eckert T, Flanagan T, Eidelberg D. Metabolic networks for assessment of therapy and diagnosis in Parkinson's disease. Mov Disord 2009; 24(Suppl 2): S725-S731.
25. Ceballos-Baumann AO. Functional imaging in Parkinson's disease: activation studies with PET, fMRI and SPECT. J Neurol 2003; 250(Suppl 1): I15-I23.
26. Jahanshahi M, Jenkins IH, Brown RG, et al. Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects. Brain 1995; 118: 913-933.
27. Samuel M, Ceballos-Baumann AO, Blin J, et al. Evidence for lateral premotor and parietal overactivity in Parkinson's disease during sequential and bimanual movements. A PET study. Brain 1997; 120: 963-976.
28. Rascol O, Sabatini U, Chollet F, et al. Normal activation of the supplementary motor area in patients with Parkinson's disease undergoing long-term treatment with levodopa. J Neurol Neurosurg Psychiatry 1994; 57: 567-571.
29. Mattay VS, Tessitore A, Callicott JH, et al. Dopaminergic modulation of cortical function in patients with Parkinson's disease. Ann Neurol 2002; 51: 156-164.
30. Jenkins IH, Fernandez W, Playford ED, et al. Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine. Ann Neurol 1992; 32: 749-757.
31. Samuel M, Ceballos-Baumann AO, Turjanski N, et al. Pallidotomy in Parkinson's disease increases supplementary motor area and prefrontal activation during performance of volitional movements an H2(15)O PET study. Brain 1997; 120: 1301-1313.
32. Rezai AR, Lozano AM, Crawley AP, et al. Thalamic stimulation and functional magnetic resonance imaging: localization of cortical and subcortical activation with implanted electrodes. Technical note. J Neurosurg 1999; 90: 583-590.
33. Jech R, Urgosik D, Tintera J, et al. Functional magnetic resonance imaging during deep brain stimulation: a pilot study in four patients with Parkinson's disease. Mov Disord 2001; 16: 1126-1132.
34. Hesselmann V, Sorger B, Girnus R, et al. Intraoperative functional MRI as a new approach to monitor deep brain stimulation in Parkinson's disease. Eur Radiol 2004; 14: 686-690.
35. Phillips MD, Baker KB, Lowe MJ, et al. Parkinson disease: pattern of functional MR imaging activation during deep brain stimulation of subthalamic nucleus-initial experience. Radiology 2006; 239: 209-216.
36. Stefurak T, Mikulis D, Mayberg H, et al. Deep brain stimulation for Parkinson's disease dissociates mood and motor circuits: a functional MRI case study. Mov Disord 2003; 18: 1508-1516.
37. Arantes PR, Cardoso EF, Barreiros MA, et al. Performing functional magnetic resonance imaging in patients with Parkinson's disease treated with deep brain stimulation. Mov Disord 2006; 21: 1154-1162.
38. Finelli DA, Rezai AR, Ruggieri PM, et al. MR imaging-related heating of deep brain stimulation electrodes: in vitro study. AJNR Am J Neuroradiol 2002; 23: 1795-1802.
39. Georgi JC, Stippich C, Tronnier VM, Heiland S. Active deep brain stimulation during MRI: a feasibility study. Magn Reson Med 2004; 51: 380-388.
40. Bhidayasiri R, Bronstein JM, Sinha S, et al. Bilateral neurostimulation systems used for deep brain stimulation: in vitro study of MRI-related heating at 1.5 T and implications for clinical imaging of the brain. Magn Reson Imaging 2005; 23: 549-555.
41. Rezai AR, Baker KB, Tkach JA, et al. Is magnetic resonance imaging safe for patients with neurostimulation systems used for deep brain stimulation? Neurosurgery 2005; 57: 1056-1062.
42. Tagliati M, Jankovic J, Pagan F, et al. Safety of MRI in patients with implanted deep brain stimulation devices. Neuroimage 2009; 47(Suppl 2): T53-T57.
43. Limousin P, Greene J, Pollak P, et al. Changes in cerebral activity pattern due to subthalamic nucleus or internal pallidum stimulation in Parkinson's disease. Ann Neurol 1997; 42: 283-291.
44. Hershey T, Revilla FJ, Wernle AR, et al. Cortical and subcortical blood flow effects of subthalamic nucleus stimulation in PD. Neurology 2003; 61: 816-821.
45. Karimi M, Golchin N, Tabbal SD, et al. Subthalamic nucleus stimulation-induced regional blood flow responses correlate with improvement of motor signs in Parkinson disease. Brain 2008; 131: 2710-2719.
46. Ceballos-Baumann AO, Boecker H, Bartenstein P, et al. A positron emission tomographic study of subthalamic nucleus stimulation in Parkinson disease: enhanced movement-related activity of motor-association cortex and decreased motor cortex resting activity. Arch Neurol 1999; 56: 997-1003.
47. Payoux P, Remy P, Damier P et al. Subthalamic nucleus stimulation reduces abnormal motor cortical overactivity in Parkinson disease. Arch Neurol 2004; 61: 1307-1313.
48. Haslinger B, Kalteis K, Boecker H, Alesch F, Ceballos-Baumann AO. Frequency-correlated decreases of motor cortex activity associated with subthalamic nucleus stimulation in Parkinson's disease. Neuroimage 2005; 28: 598-606.
49. Grafton ST, Turner RS, Desmurget M, et al. Normalizing motor-related brain activity: subthalamic nucleus stimulation in Parkinson disease. Neurology 2006; 66: 1192-1199.
50. Geday J, Ostergaard K, Johnsen E, Gjedde A. STN-stimulation in Parkinson's disease restores striatal inhibition of thalamocortical projection. Hum Brain Mapp 2009; 30: 112-121.
51. Hilker R, Voges J, Weber T, et al. STN-DBS activates the target area in Parkinson disease: an FDG-PET study. Neurology 2008; 71: 708-713.
52. Lewis MM, Slagle CG, Smith AB, et al. Task specific influences of Parkinson's disease on the striato-thalamo-cortical and cerebello-thalamo-cortical motor circuitries. Neuroscience 2007; 147: 224-235.
53. Hilker R, Voges J, Weisenbach S, et al. Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: evidence from a FDG-PET study in advanced Parkinson's disease. J Cereb Blood Flow Metab 2004; 24: 7-16.
54. Buckner RL, ndrews-Hanna JR, Schacter DL. The brain's default network: anatomy, function, and relevance to disease. Ann N Y Acad Sci 2008; 1124: 1-38.
55. van Eimeren T., Monchi O, Ballanger B, Strafella AP. Dysfunction of the default mode network in Parkinson disease: a functional magnetic resonance imaging study. Arch Neurol 2009; 66: 877-883.
56. Thobois S, Dominey P, Fraix V, et al. Effects of subthalamic nucleus stimulation on actual and imagined movement in Parkinson's disease: a PET study. J Neurol 2002; 249: 1689-1698.
57. Yelnik J, Bardinet E, Dormont D, et al. A three-dimensional, histological and deformable atlas of the human basal ganglia. I. Atlas construction based on immunohistochemical and MRI data. Neuroimage 2007; 34: 618-638.
58. Mallet L, Schupbach M, N'Diaye K, et al. Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior. Proc Natl Acad Sci U S A 2007; 104: 10661-10666.
59. Kalbe E, Voges J, Weber T, et al. Frontal FDG-PET activity correlates with cognitive outcome after STN-DBS in Parkinson disease. Neurology 2009; 72: 42-49.
60. Bejjani BP, Damier P, Arnulf I, et al. Transient acute depression induced by high-frequency deep-brain stimulation. N Engl J Med 1999; 340: 1476-1480.
61. Temel Y, Kessels A, Tan S, et al. Behavioural changes after bilateral subthalamic stimulation in advanced Parkinson disease: a systematic review. Parkinsonism Relat Disord 2006; 12: 265-272.
62. Ulla M, Thobois S, Lemaire JJ, et al. Manic behaviour induced by deep-brain stimulation in Parkinson's disease: evidence of substantia nigra implication? J Neurol Neurosurg Psychiatry 2006; 77: 1363-1366.
63. Witt K, Daniels C, Reiff J, et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study. Lancet Neurol 2008; 7: 605-614.
64. Saint-Cyr JA, Trepanier LL, Kumar R, Lozano AM, Lang AE. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain 2000; 123: 2091-2108.
65. Funkiewiez A, Ardouin C, Caputo E, et al. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease. J Neurol Neurosurg Psychiatry 2004; 75: 834-839.
66. Frith CD, Friston KJ, Liddle PF, Frackowiak RS. A PET study of word finding. Neuropsychologia 1991; 29: 1137-1148.
67. Schroeder U, Kuehler A, Lange KW, et al. Subthalamic nucleus stimulation affects a frontotemporal network: a PET study. Ann Neurol 2003; 54: 445-450.
68. Cilia R, Siri C, Marotta G, et al. Brain networks underlining verbal fluency decline during STN-DBS in Parkinson's disease: an ECD-SPECT study. Parkinsonism Relat Disord 2007; 13: 290-294.
69. Schroeder U, Kuehler A, Haslinger B, et al. Subthalamic nucleus stimulation affects striato-anterior cingulate cortex circuit in a response conflict task: a PET study. Brain 2002; 125: 1995-2004.
70. Jahanshahi M, Ardouin CM, Brown RG, et al. The impact of deep brain stimulation on executive function in Parkinson's disease. Brain 2000; 123: 1142-1154.
71. Thobois S, Hotton GR, Pinto S, et al. STN stimulation alters pallidal-frontal coupling during response selection under competition. J Cereb Blood Flow Metab 2007; 27: 1173-1184.
72. Mink JW, Thach WT. Basal ganglia intrinsic circuits and their role in behavior. Curr Opin Neurobiol 1993; 3: 950-957.
73. Kropotov JD, Etlinger SC. Selection of actions in the basal ganglia-thalamocortical circuits: review and model. Int J Psychophysiol 1999; 31: 197-217.
74. Frank MJ, Samanta J, Moustafa AA, Sherman SJ. Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism. Science 2007; 318: 1309-1312.
75. Appleby BS, Duggan PS, Regenberg A, Rabins PV. Psychiatric and neuropsychiatric adverse events associated with deep brain stimulation: a meta-analysis of ten years' experience. Mov Disord 2007; 22: 1722-1728.
76. LeJeune F, Peron J, Biseul I, et al. Subthalamic nucleus stimulation affects orbitofrontal cortex in facial emotion recognition: a PET study. Brain 2008; 131: 1599-1608.
77. LeJeune F, Drapier D, Bourguignon A, et al. Subthalamic nucleus stimulation in Parkinson disease induces apathy: a PET study. Neurology 2009; 73: 1746-1751.
78. Ulla M, Thobois S, Llorca PM, et al. Contact dependent reproducible hypomania induced by deep brain stimulation in Parkinson's disease: clinical, anatomical and functional imaging study. J Neurol Neurosurg Psychiatry 2011; 82: 607-614.
79. Stefurak T, Mikulis D, Mayberg H et al. Deep brain stimulation for Parkinson's disease dissociates mood and motor circuits: a functional MRI case study. Mov Disord 2003; 18: 1508-1516.
80. Yu H, Sternad D, Corcos DM, Vaillancourt DE. Role of hyperactive cerebellum and motor cortex in Parkinson's disease. Neuroimage 2007; 35: 222-233.
81. Rowe J, Stephan KE, Friston K, et al. Attention to action in Parkinson's disease: impaired effective connectivity among frontal cortical regions. Brain 2002; 125: 276-289.
82. Sestini S, Scotto di LA, Ammannati F, et al. Changes in regional cerebral blood flow caused by deep-brain stimulation of the subthalamic nucleus in Parkinson's disease. J Nucl Med 2002; 43: 725-732.
83. Johansen KK, Jorgensen JV, White LR, Farrer MJ, Aasly JO. Parkinson-related genetics in patients treated with deep brain stimulation. Acta Neurol Scand 2011; 123: 201-206.
84. Healy DG, Falchi M, O'sullivan SS, et al. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neurol 2008; 7: 583-590.
85. Hashimoto T, Elder CM, Okun MS, Patrick SK, Vitek JL. Stimulation of the subthalamic nucleus changes the firing pattern of pallidal neurons. J Neurosci 2003; 23: 1916-1923.
86. Haslinger B, Erhard P, Kampfe N, et al. Event-related functional magnetic resonance imaging in Parkinson's disease before and after levodopa. Brain 2001; 124: 558-570.
87. Dagher A, Nagano-Saito A. Functional and anatomical magnetic resonance imaging in Parkinson's disease. Mol Imaging Biol 2007; 9: 234-242.
88. Gradinaru V, Mogri M, Thompson KR, Henderson JM, Deisseroth K. Optical deconstruction of parkinsonian neural circuitry. Science 2009; 324: 354-359.
89. Strafella AP, Dagher A, Sadikot AF. Cerebral blood flow changes induced by subthalamic stimulation in Parkinson's disease. Neurology 2003; 60: 1039-1042.